{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:45:46Z","timestamp":1793400346490,"version":"4.5.0"},"reference-count":121,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Pemphigus vulgaris is a chronic autoimmune mucocutaneous blistering disorder. Apart from the disease itself, other aspects of patients\u2019 life, including psychological, social, and financial, can be affected. Women are particularly more disposed to the impact of the disease due to their physiological characteristics, the specific periods of pregnancy and lactation as well as their social and familial role. In this review, we summarized the burden of pemphigus vulgaris on various aspects of women\u2019s lives. It is essential to understand these problems and provide appropriate support for patients with such a burdensome disease.<\/jats:p>","DOI":"10.1097\/jw9.0000000000000056","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T17:01:21Z","timestamp":1664816481000},"page":"e056","source":"Crossref","is-referenced-by-count":14,"title":["Burden of pemphigus vulgaris with a particular focus on women: A review"],"prefix":"10.1097","volume":"8","author":[{"given":"Nika","family":"Kianfar","sequence":"first","affiliation":[{"name":"Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayan","family":"Dasdar","sequence":"additional","affiliation":[{"name":"Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Mahmoudi","sequence":"additional","affiliation":[{"name":"Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Daneshpazhooh","sequence":"additional","affiliation":[{"name":"Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"key":"R1-20231102","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1590\/abd1806-4841.20199011","article-title":"Pemphigus vulgaris.","volume":"94","author":"Porro","year":"2019","journal-title":"An Bras Dermatol"},{"key":"R2-20231102","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaci.2020.02.013","article-title":"Autoimmune bullous skin diseases, pemphigus and pemphigoid.","volume":"145","author":"Egami","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"R3-20231102","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijwd.2015.01.002","article-title":"Autoimmune blistering diseases in females: a review.","volume":"1","author":"Zhao","year":"2015","journal-title":"Int J Women\u2019s Dermatol"},{"key":"R4-20231102","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00403-014-1531-1","article-title":"Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid.","volume":"307","author":"Alpsoy","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"R5-20231102","first-page":"434","article-title":"Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany.","volume":"7","author":"Bertram","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"R6-20231102","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2340\/0001555562491496","article-title":"Pemphigus: an epidemiological study of patients treated in Finnish hospitals between 1969 and 1978.","volume":"62","author":"Hietanen","year":"1982","journal-title":"Acta Derm Venereol"},{"key":"R7-20231102","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-4632.2004.02501.x","article-title":"Pemphigus: analysis of 1209 cases.","volume":"44","author":"Chams-Davatchi","year":"2005","journal-title":"Int J Dermatol"},{"key":"R8-20231102","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0030-4220(74)90365-X","article-title":"Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion.","volume":"38","author":"Pisanti","year":"1974","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"R9-20231102","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/archderm.1980.01640330073017","article-title":"Pemphigus in Hartford County, Connecticut, from 1972 to 1977.","volume":"116","author":"Simon","year":"1980","journal-title":"Arch Dermatol"},{"key":"R10-20231102","doi-asserted-by":"crossref","first-page":"100004","DOI":"10.1016\/j.xjidi.2021.100004","article-title":"Epidemiology of pemphigus.","volume":"1","author":"Kridin","year":"2021","journal-title":"JID Innovations"},{"key":"R11-20231102","doi-asserted-by":"crossref","first-page":"7658","DOI":"10.1073\/pnas.87.19.7658","article-title":"Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris.","volume":"87","author":"Ahmed","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"R12-20231102","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3906\/sag-2006-231","article-title":"A survey of bullous diseases in a Turkish university hospital: clinicoepidemiological characteristics and follow-up.","volume":"51","author":"Kutlubay","year":"2021","journal-title":"Turk J Med Sci"},{"key":"R13-20231102","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/jdv.16752","article-title":"Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the European Academy of Dermatology and Venereology (EADV).","volume":"34","author":"Joly","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R14-20231102","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(19)31778-7","article-title":"Pemphigus.","volume":"394","author":"Schmidt","year":"2019","journal-title":"Lancet"},{"key":"R15-20231102","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/17512433.2019.1670059","article-title":"What is novel in the clinical management of pemphigus.","volume":"12","author":"Bilgic","year":"2019","journal-title":"Expert Rev Clin Pharmacol"},{"key":"R16-20231102","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jaad.2018.02.021","article-title":"Diagnosis and management of pemphigus: recommendations of an international panel of experts.","volume":"82","author":"Murrell","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R17-20231102","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.3389\/fimmu.2019.01418","article-title":"Pemphigus: current and future therapeutic strategies.","volume":"10","author":"Didona","year":"2019","journal-title":"Front Immunol"},{"key":"R18-20231102","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(17)30070-3","article-title":"First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.","volume":"389","author":"Joly","year":"2017","journal-title":"Lancet"},{"key":"R19-20231102","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa2028564","article-title":"Rituximab versus mycophenolate mofetil in patients with pemphigus vulgaris.","volume":"384","author":"Werth","year":"2021","journal-title":"N Engl J Med"},{"key":"R20-20231102","first-page":"6","article-title":"Rituximab in childhood and juvenile autoimmune bullous diseases as first-line and second-line treatment: a case series of 13 patients.","volume":"1","author":"Kianfar","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"R21-20231102","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jdin.2021.10.002","article-title":"Efficacy of rituximab in pediatric pemphigus: a literature review.","volume":"6","author":"Patel","year":"2022","journal-title":"JAAD Int"},{"key":"R22-20231102","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1111\/jdv.14119","article-title":"Pregnancy outcome after rituximab treatment before conception in patients affected by severe pemphigus vulgaris\/superficialis.","volume":"31","author":"Vassallo","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R23-20231102","doi-asserted-by":"crossref","first-page":"e038","DOI":"10.1097\/JW9.0000000000000038","article-title":"Pregnancy outcomes in women with pemphigus exposed to rituximab before or during pregnancy.","volume":"8","author":"Dehghanimahmoudabadi","year":"2022","journal-title":"Int J Women\u2019s Dermatol"},{"key":"R24-20231102","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3390\/medicina57101080","article-title":"An updated review of pemphigus diseases.","volume":"57","author":"Malik","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"R25-20231102","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0190-9622(90)70004-2","article-title":"Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies.","volume":"22","author":"Tan-Lim","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"R26-20231102","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2008.09.052","article-title":"A randomized double-blind trial of intravenous immunoglobulin for pemphigus.","volume":"60","author":"Amagai","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R27-20231102","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2147\/TCRM.S142471","article-title":"Emerging treatment options for the management of pemphigus vulgaris.","volume":"14","author":"Kridin","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"R28-20231102","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jdin.2021.09.003","article-title":"Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease using the Glucocorticoid Toxicity Index: a cohort study.","volume":"6","author":"Liang","year":"2022","journal-title":"JAAD Int"},{"key":"R29-20231102","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ijwd.2021.07.014","article-title":"Corticosteroid use in chronic dermatologic disorders and osteoporosis.","volume":"7","author":"Lupsa","year":"2021","journal-title":"Int J Women\u2019s Dermatol"},{"key":"R30-20231102","doi-asserted-by":"crossref","first-page":"101369","DOI":"10.1016\/j.beem.2019.101369","article-title":"Infertility in women with systemic autoimmune diseases.","volume":"33","author":"Khizroeva","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R31-20231102","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0190-9622(97)80213-7","article-title":"Infertility in women with pemphigus vulgaris and other autoimmune diseases.","volume":"36","author":"Ouahes","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"R32-20231102","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.intimp.2017.11.005","article-title":"Sixteen-year history of rituximab therapy for 1085 pemphigus vulgaris patients: a systematic review.","volume":"54","author":"Tavakolpour","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"R33-20231102","first-page":"727","article-title":"Efficacy and safety of rituximab in pemphigus: experience of the German Registry of Autoimmune Diseases.","volume":"10","author":"Kasperkiewicz","year":"2012","journal-title":"J Dtsch Dermatol Ges"},{"key":"R34-20231102","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1365-2133.2011.10575.x","article-title":"British Association of Dermatologists\u2019 guidelines for the safe and effective prescribing of azathioprine 2011.","volume":"165","author":"Meggitt","year":"2011","journal-title":"Br J Dermatol"},{"key":"R35-20231102","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clindermatol.2011.03.013","article-title":"Immunosuppressive therapy for autoimmune bullous diseases.","volume":"30","author":"Meurer","year":"2012","journal-title":"Clin Dermatol"},{"key":"R36-20231102","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4103\/0378-6323.82404","article-title":"Pemphigus and pregnancy: a 23-year experience.","volume":"77","author":"Daneshpazhooh","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R37-20231102","doi-asserted-by":"crossref","first-page":"256","DOI":"10.23736\/S0392-0488.18.06153-9","article-title":"Autoimmune bullous diseases during pregnancy: insight into pathogenetic mechanisms and clinical features.","volume":"154","author":"Feliciani","year":"2019","journal-title":"G Ital Dermatol Venereol"},{"key":"R38-20231102","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12601","article-title":"Management of pemphigus disease in pregnancy.","volume":"77","author":"Tavakolpour","year":"2017","journal-title":"Am J Reprod Immunol"},{"key":"R39-20231102","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/sji.12453","article-title":"New insights into the management of patients with autoimmune diseases or inflammatory disorders during pregnancy.","volume":"84","author":"Tavakolpour","year":"2016","journal-title":"Scand J Immunol"},{"key":"R40-20231102","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.abd.2020.10.007","article-title":"Autoimmune bullous diseases in pregnancy: clinical and epidemiological characteristics and therapeutic approach.","volume":"96","author":"Fagundes","year":"2021","journal-title":"An Bras Dermatol"},{"key":"R41-20231102","first-page":"796590","article-title":"Adherence with drug therapy in pregnancy.","volume":"2012","author":"Matsui","year":"2012","journal-title":"Obstetr Gynecol Int"},{"key":"R42-20231102","first-page":"166","article-title":"Trauma-induced pemphigus: a case series of 36 patients.","volume":"14","author":"Daneshpazhooh","year":"2016","journal-title":"JDDG: Journal der Deutschen Dermatologischen Gesellschaft"},{"key":"R43-20231102","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/OGX.0b013e3181bea089","article-title":"Pemphigus vulgaris in pregnancy: analysis of current data on the management and outcomes.","volume":"64","author":"Kardos","year":"2009","journal-title":"Obstet Gynecol Surv"},{"key":"R44-20231102","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.15537\/smj.2015.9.12270","article-title":"Pemphigus and pregnancy. Analysis and summary of case reports over 49 years.","volume":"36","author":"Lin","year":"2015","journal-title":"Saudi Med J"},{"key":"R45-20231102","first-page":"144","article-title":"Pemphigus vulgaris and pregnancy.","volume":"8","author":"Drenovska","year":"2010","journal-title":"Skinmed"},{"key":"R46-20231102","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s40257-018-0342-0","article-title":"Treatment of autoimmune bullous disorders in pregnancy.","volume":"19","author":"Kushner","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"R47-20231102","doi-asserted-by":"crossref","first-page":"583354","DOI":"10.3389\/fphar.2020.583354","article-title":"Treatment of autoimmune bullous diseases during pregnancy and lactation: a review focusing on pemphigus and pemphigoid gestationis.","volume":"11","author":"Genovese","year":"2020","journal-title":"Front Pharmacol"},{"key":"R48-20231102","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/humupd\/dmaa022","article-title":"The effect of paternal exposure to immunosuppressive drugs on sexual function, reproductive hormones, fertility, pregnancy and offspring outcomes: a systematic review.","volume":"26","author":"Perez-Garcia","year":"2020","journal-title":"Hum Reprod Update"},{"key":"R49-20231102","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/j.gastro.2021.03.020","article-title":"Paternal exposure to immunosuppressive and\/or biologic agents and birth outcomes in patients with immune-mediated inflammatory diseases.","volume":"161","author":"Meserve","year":"2021","journal-title":"Gastroenterology"},{"key":"R50-20231102","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ced.14916","article-title":"Comorbid mental health issues in patients with pemphigus vulgaris and pemphigus foliaceus.","volume":"47","author":"Matthews","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"R51-20231102","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/jamadermatol.2021.4055","article-title":"Bullous dermatoses and depression: a systematic review.","volume":"157","author":"Pourali","year":"2021","journal-title":"JAMA Dermatol"},{"key":"R52-20231102","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1684\/ejd.2015.2649","article-title":"Pemphigus and depression comorbidity: a case control study.","volume":"25","author":"Wohl","year":"2015","journal-title":"Eur J Dermatol"},{"key":"R53-20231102","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.3390\/ijerph17061983","article-title":"The risk of depression in patients with pemphigus: a nationwide cohort study in Taiwan.","volume":"17","author":"Hsu","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"R54-20231102","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4103\/0019-5154.87151","article-title":"Mental health in patients with pemphigus: an issue to worth consideration.","volume":"56","author":"Arbabi","year":"2011","journal-title":"Indian J Dermatol"},{"key":"R55-20231102","first-page":"57","article-title":"Assessment of the quality of life, prevalence of depression, and the level of interleukin 6 in patients with pemphigus vulgaris.","volume":"28","author":"Metwally","year":"2020","journal-title":"Acta Dermatovenerol Croat"},{"key":"R56-20231102","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5021\/ad.2015.27.5.492","article-title":"Quality of life assessment in korean patients with pemphigus.","volume":"27","author":"Sung","year":"2015","journal-title":"Ann Dermatol"},{"key":"R57-20231102","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaad.2008.09.014","article-title":"Quality-of-life assessment in patients with pemphigus using a minimum set of evaluation tools.","volume":"60","author":"Paradisi","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R58-20231102","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ajp.2012.10.005","article-title":"Psychiatric morbidity in pemphigus and psoriasis: a comparative study from India.","volume":"6","author":"Kumar","year":"2013","journal-title":"Asian J Psychiatr"},{"key":"R59-20231102","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1017\/S204579601700052X","article-title":"Association between schizophrenia and an autoimmune bullous skin disease-pemphigus: a population-based large-scale study.","volume":"28","author":"Kridin","year":"2019","journal-title":"Epidemiol Psychiatr Sci"},{"key":"R60-20231102","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1177\/0706743717740344","article-title":"Bipolar disorder associated with another autoimmune disease-pemphigus: a population-based study.","volume":"63","author":"Kridin","year":"2018","journal-title":"Can J Psychiatry"},{"key":"R61-20231102","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/bjd.18548","article-title":"Post-traumatic stress disorder in patients with autoimmune blistering diseases.","volume":"182","author":"Wei","year":"2020","journal-title":"Br J Dermatol"},{"key":"R62-20231102","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1440-1819.2011.02260.x","article-title":"Psychiatric complications of treatment with corticosteroids: review with case report.","volume":"65","author":"Kenna","year":"2011","journal-title":"Psychiatry Clin Neurosci"},{"key":"R63-20231102","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1365-2133.2008.08481.x","article-title":"The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire.","volume":"158","author":"Tabolli","year":"2008","journal-title":"Br J Dermatol"},{"key":"R64-20231102","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/bjd.12836","article-title":"Burden of disease during quiescent periods in patients with pemphigus.","volume":"170","author":"Tabolli","year":"2014","journal-title":"Br J Dermatol"},{"key":"R65-20231102","first-page":"26","article-title":"Psychological morbidity in pemphigus patients in clinical remission and its relation with clinico-demographic parameters.","volume":"20","author":"De","year":"2021","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology: JDDG"},{"key":"R66-20231102","first-page":"26","article-title":"Psychological morbidity in pemphigus patients in clinical remission and its relation with clinico-demographic parameters.","volume":"20","author":"De","year":"2022","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology: JDDG"},{"key":"R67-20231102","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jdin.2022.01.004","article-title":"The positive impact of rituximab on the quality of life and mental health in patients with pemphigus.","volume":"7","author":"Rashid","year":"2022","journal-title":"JAAD Int"},{"key":"R68-20231102","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000111506","article-title":"Stressful life events and pemphigus.","volume":"216","author":"Morell-Dubois","year":"2008","journal-title":"Dermatology"},{"key":"R69-20231102","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1001\/archderm.134.11.1486","article-title":"Stressful life events as potential triggers of pemphigus.","volume":"134","author":"Cremniter","year":"1998","journal-title":"Arch Dermatol"},{"key":"R70-20231102","article-title":"Anxiety and depression predispose individuals to an autoimmune bullous diseases- bullous pemphigoid: a large-scale population-based cohort study.","author":"Kridin","year":"2021","journal-title":"Curr Psychol"},{"key":"R71-20231102","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1468-3083.2010.03780.x","article-title":"Psychological distress and investment in one\u2019s appearance in patients with pemphigus.","volume":"25","author":"Mazzotti","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R72-20231102","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fpsyt.2019.00030","article-title":"Cytokine research in depression: principles, challenges, and open questions.","volume":"10","author":"Himmerich","year":"2019","journal-title":"Front Psychiatry"},{"key":"R73-20231102","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1038\/tp.2016.92","article-title":"Cytokine production capacity in depression and anxiety.","volume":"6","author":"Vogelzangs","year":"2016","journal-title":"Transl Psychiatry"},{"key":"R75-20231102","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jad.2017.10.027","article-title":"Systemic autoimmune diseases are associated with an increased risk of bipolar disorder: a nationwide population-based cohort study.","volume":"227","author":"Wang","year":"2018","journal-title":"J Affect Disord"},{"key":"R76-20231102","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1001\/jama.2015.16353","article-title":"Training physicians to provide high-value, cost-conscious care: a systematic review.","volume":"314","author":"Stammen","year":"2015","journal-title":"JAMA"},{"key":"R77-20231102","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/jamadermatol.2015.5240","article-title":"Costs of care for hospitalization for pemphigus in the United States.","volume":"152","author":"Hsu","year":"2016","journal-title":"JAMA Dermatol"},{"key":"R78-20231102","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jdermsci.2020.08.002","article-title":"National trends in incidence, mortality, hospitalizations, and expenditures for pemphigus in Taiwan.","volume":"99","author":"Chiu","year":"2020","journal-title":"J Dermatol Sci"},{"key":"R79-20231102","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/bjd.18731","article-title":"Assessment of healthcare costs for patients with pemphigus and bullous pemphigoid in an academic centre in Germany.","volume":"182","author":"St\u00e4nder","year":"2020","journal-title":"Br J Dermatol"},{"key":"R80-20231102","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/14737167.2020.1722104","article-title":"Disease burden of patients with pemphigus from a societal perspective.","volume":"21","author":"Brodszky","year":"2021","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"R81-20231102","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40257-020-00544-w","article-title":"Novel therapies for pemphigus vulgaris.","volume":"21","author":"Altman","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"R82-20231102","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.intimp.2005.11.002","article-title":"Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.","volume":"6","author":"Daoud","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"R83-20231102","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/bjd.18563","article-title":"Comparison of real costs in the French healthcare system in newly diagnosed patients with pemphigus for first-line treatment with rituximab vs. standard corticosteroid regimen: data from a national multicentre trial.","volume":"183","author":"H\u00e9bert","year":"2020","journal-title":"Br J Dermatol"},{"key":"R84-20231102","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2310\/7750.2014.14092","article-title":"Cost and resource use of pemphigus and pemphigoid disorders pre- and post-rituximab.","volume":"19","author":"Heelan","year":"2015","journal-title":"J Cutan Med Surg"},{"key":"R85-20231102","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4103\/ijd.IJD_306_20","article-title":"A comparative study to evaluate the efficacy and cost of rituximab versus dexamethasone cyclophosphamide pulse in patients of pemphigus vulgaris.","volume":"66","author":"Das","year":"2021","journal-title":"Indian J Dermatol"},{"key":"R86-20231102","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/bjd.12630","article-title":"Prognostic factors in pemphigus vulgaris and pemphigus foliaceus.","volume":"170","author":"Saha","year":"2014","journal-title":"Br J Dermatol"},{"key":"R87-20231102","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1046\/j.1468-3083.2002.00504.x","article-title":"Pemphigus vulgaris: a review of treatment over a 19-year period.","volume":"16","author":"Ljubojevi\u0107","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R88-20231102","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/1049732318803590","article-title":"Individuals with the rare disease pemphigus: a quest for diagnostic.","volume":"29","author":"Le H\u00e9naff","year":"2019","journal-title":"Qual Health Res"},{"key":"R89-20231102","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/jop.13052","article-title":"Clinical presentation and diagnostic delay in pemphigus vulgaris: a prospective study from Turkey.","volume":"49","author":"Daltaban","year":"2020","journal-title":"J Oral Pathol Med"},{"key":"R90-20231102","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/odi.12839","article-title":"Diagnostic patterns and delays in autoimmune blistering diseases of the mouth: a cross-sectional study.","volume":"24","author":"Hassona","year":"2018","journal-title":"Oral Dis"},{"key":"R91-20231102","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/archderm.136.12.1569","article-title":"Diagnostic patterns and delays in pemphigus vulgaris: experience with 99 patients.","volume":"136","author":"Sirois","year":"2000","journal-title":"Arch Dermatol"},{"key":"R92-20231102","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/odi.12639","article-title":"Oral mucous membrane pemphigoid and pemphigus vulgaris-a retrospective two-center cohort study.","volume":"23","author":"Sultan","year":"2017","journal-title":"Oral Dis"},{"key":"R93-20231102","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2340\/00015555-1854","article-title":"Development of a disease registry for autoimmune bullous diseases: initial analysis of the pemphigus vulgaris subset.","volume":"95","author":"Shah","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"R94-20231102","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1177\/10547738211002354","article-title":"What does it mean to be pemphigus patient? A qualitative study.","volume":"30","author":"Okcin","year":"2021","journal-title":"Clin Nurs Res"},{"key":"R95-20231102","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijwd.2017.11.001","article-title":"The effects of autoimmune blistering diseases on work productivity: a review.","volume":"4","author":"Wang","year":"2018","journal-title":"Int J Womens Dermatol"},{"key":"R96-20231102","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/jdv.15062","article-title":"The effect of autoimmune blistering diseases on work productivity.","volume":"32","author":"Wang","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R97-20231102","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/bjd.14463","article-title":"Comorbidities and inpatient mortality for pemphigus in the U.S.A.","volume":"174","author":"Hsu","year":"2016","journal-title":"Br J Dermatol"},{"key":"R98-20231102","doi-asserted-by":"crossref","DOI":"10.5070\/D32312037664","article-title":"Association of pemphigus and systemic corticosteroid use with comorbid health disorders: a case-control study.","volume":"23","author":"Hsu","year":"2017","journal-title":"Dermatol Online J"},{"key":"R99-20231102","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.oooo.2013.08.006","article-title":"Dietary alterations in patients with oral vesiculoulcerative diseases.","volume":"117","author":"Czerninski","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"R100-20231102","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/1467-9566.12987","article-title":"Engagement in leisure and physical activities: analysing the biographical disruptions of a rare chronic disease in France.","volume":"42","author":"Le H\u00e9naff","year":"2020","journal-title":"Sociol Health Illn"},{"key":"R101-20231102","first-page":"29","article-title":"The effect of leisure time physical activities on quality of life and clinical symptoms of pemphigus vulgaris.","volume":"15","author":"Momtazbakhsh","year":"2020","journal-title":"Iranian J Nurs Res"},{"key":"R102-20231102","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2133.2007.08356.x","article-title":"Cervicovaginal involvement in pemphigus vulgaris: a clinical study of 77 cases.","volume":"158","author":"Akhyani","year":"2008","journal-title":"Br J Dermatol"},{"key":"R103-20231102","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4172\/lpma.1000268","article-title":"Exploring pemphigus challenges based on the patient experiences: a descriptive phenomenological research.","volume":"103","author":"Piri","year":"2017","journal-title":"Prensa Med Argent"},{"key":"R104-20231102","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4103\/ijdvl.IJDVL_276_18","article-title":"Family dermatology life quality index in patients with pemphigus vulgaris: a cross-sectional study.","volume":"87","author":"Sajedianfard","year":"2021","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R105-20231102","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ijwd.2020.09.004","article-title":"Family impact of pemphigus disease in an Iranian population using the Family Dermatology Life Quality Index.","volume":"6","author":"Ghodsi","year":"2020","journal-title":"Int J Womens Dermatol"},{"key":"R106-20231102","first-page":"1","article-title":"The effect of family-centered empowerment model on quality of life of female patients with pemphigus vulgaris referred to Razi hospital.","volume":"13","author":"Ghasemi","year":"2018","journal-title":"IJNR"},{"key":"R107-20231102","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0151-9638(05)79276-0","article-title":"Quality of life and pemphigus.","volume":"132","author":"Terrab","year":"2005","journal-title":"Ann Dermatol Venereol"},{"key":"R108-20231102","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/bjd.13848","article-title":"Health-related quality of life and its determinants in pemphigus: a systematic review and meta-analysis.","volume":"173","author":"Rencz","year":"2015","journal-title":"Br J Dermatol"},{"key":"R109-20231102","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1610-0387.2005.05722.x","article-title":"Significant decrease in quality of life in patients with pemphigus vulgaris. Results from the German Bullous Skin Disease (BSD) Study Group.","volume":"3","author":"Mayrshofer","year":"2005","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft = J German Soc Dermatol: JDDG"},{"key":"R110-20231102","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1346-8138.2011.01382.x","article-title":"Quality of life and psychological status of patients with pemphigus vulgaris using Dermatology Life Quality Index and General Health Questionnaires.","volume":"39","author":"Ghodsi","year":"2012","journal-title":"J Dermatol"},{"key":"R111-20231102","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10198-019-01067-w","article-title":"Subjective well-being in patients with pemphigus: a path analysis.","volume":"20","author":"Mitev","year":"2019","journal-title":"Eur J Health Economics"},{"key":"R112-20231102","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jamadermatol.2013.4972","article-title":"Development of a quality-of-life instrument for autoimmune bullous disease: the Autoimmune Bullous Disease Quality of Life questionnaire.","volume":"149","author":"Sebaratnam","year":"2013","journal-title":"JAMA Dermatol"},{"key":"R113-20231102","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s11136-015-0965-z","article-title":"Reliability of the autoimmune bullous disease quality of life (ABQOL) questionnaire in the USA.","volume":"24","author":"Sebaratnam","year":"2015","journal-title":"Qual Life Res"},{"key":"R114-20231102","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.advms.2016.07.002","article-title":"Measuring of quality of life in autoimmune blistering disorders in Poland. Validation of disease - specific Autoimmune Bullous Disease Quality of Life (ABQOL) and the Treatment Autoimmune Bullous Disease Quality of Life (TABQOL) questionnaires.","volume":"62","author":"Kalinska-Bienias","year":"2017","journal-title":"Adv Med Sci"},{"key":"R115-20231102","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12955-017-0594-z","article-title":"Reliability and validity of the Chinese version of the autoimmune bullous disease quality of life (ABQOL) questionnaire.","volume":"15","author":"Yang","year":"2017","journal-title":"Health Qual Life Outcomes"},{"key":"R116-20231102","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1590\/abd1806-4841.20197198","article-title":"Assessment of the quality of life of Egyptian and Tunisian autoimmune bullous diseases\u2019 patients using an Arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires.","volume":"94","author":"Saleh","year":"2019","journal-title":"Anais brasileiros de dermatologia"},{"key":"R117-20231102","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ijwd.2020.03.043","article-title":"Autoimmune Bullous Disease Quality of Life (ABQoL) questionnaire: validation of the translated Persian version in pemphigus vulgaris.","volume":"6","author":"Teimourpour","year":"2020","journal-title":"Int J Women\u2019s Dermatol"},{"key":"R118-20231102","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2340\/00015555-2737","article-title":"Quality of life in Greek patients with autoimmune bullous diseases assessed with ABQOL and TABQOL indexes.","volume":"97","author":"Patsatsi","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"R119-20231102","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/bjd.19173","article-title":"Sensitivity to change and correlation between the autoimmune bullous disease quality-of-life questionnaires ABQOL and TABQOL, and objective severity scores.","volume":"183","author":"Ferries","year":"2020","journal-title":"Br J Dermatol"},{"key":"R120-20231102","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/bjd.12623","article-title":"The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease.","volume":"169","author":"Tjokrowidjaja","year":"2013","journal-title":"Br J Dermatol"},{"key":"R121-20231102","doi-asserted-by":"crossref","first-page":"e004","DOI":"10.1097\/JW9.0000000000000004","article-title":"Assessing Quality of Life in Patients with Autoimmune Bullous Diseases Using the Persian Version of Treatment of Autoimmune Bullous Disease Quality of Life (TABQOL) Questionnaire finds similar effects in women as men.","volume":"8","author":"Behkar","year":"2021","journal-title":"Int J Women\u2019s Dermatol"},{"key":"R122-20231102","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4103\/ijdvl.IJDVL_538_16","article-title":"Chinese version of the treatment of autoimmune bullous disease quality of life questionnaire: reliability and validity.","volume":"84","author":"Chen","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"}],"container-title":["International Journal of Women\u2019s Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JW9.0000000000000056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T18:25:58Z","timestamp":1698949558000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JW9.0000000000000056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":121,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/jw9.0000000000000056","relation":{},"ISSN":["2352-6475"],"issn-type":[{"value":"2352-6475","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}